Page 3 - ட மூலக்கூறு சிகிச்சை இன்க் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ட மூலக்கூறு சிகிச்சை இன்க். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ட மூலக்கூறு சிகிச்சை இன்க் Today - Breaking & Trending Today

4D Molecular Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares


Message :
Required fields
EMERYVILLE, Calif., Dec. 15, 2020 (GLOBE NEWSWIRE) 4D Molecular Therapeutics, Inc. (4DMT), a clinical-stage gene therapy company harnessing the power of directed evolution for targeted gene therapies, announced today the closing of its initial public offering of 9,660,000 shares of its common stock, including 1,260,000 shares sold pursuant to the full exercise of the underwriters’ option to purchase additional shares, at a price of $23.00 per share. The aggregate gross proceeds of the offering were approximately $222 million, before deducting underwriting discounts and commissions and other offering expenses. The shares began trading on the Nasdaq Global Select Market on December 11, 2020 under the ticker symbol “FDMT.” ....

New York , United States , North Carolina , Mike Zanoni , Theresa Janke , Exchange Commission , Prospectus Department , Goldman Sachs Co , D Molecular Therapeutics Inc , Evercore Group , Molecular Therapeutics , Nasdaq Global Select Market , Bofa Securities , Goldman Sachs , College Street , Equity Capital Markets , Therapeutic Vector Evolution , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் , வடக்கு கரோலினா , மைக் ஜஞோநி , தெரேசா ஜான்கே , பரிமாற்றம் தரகு , ப்ரோஸ்பெக்டஸ் துறை , கோல்ட்மேன் சாக்ஸ் இணை , ட மூலக்கூறு சிகிச்சை இன்க் ,